Grifols sa bloomberg

Stock analysis for Grifols SA (GRF/P:Soc.Bol SIBE) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Grifols, S.A. a specialty biopharmaceutical company, develops, manufactures, and distributes plasma derivative products in the United States, Canada, Spain. Stock analysis for Grifols SA (GRFS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

GRIFOLS SA - B (GRF/P:SM) stock price & investing information. Find GRIFOLS SA - B historical stock quotes, key competitors, stock data, executives and. View GRIFOLS SA (GRF:Continuous) Board of Directors profiles, including company insiders and other company Board Members.

Find GRIFOLS SA (GRF:SM) financials to make informed financial statement analysis. Review income statement, balance sheet & cash flow statements. The share capital of Grifols S.A. currently stands at 119,603,705 euros, represented by: Shares Class A: Bloomberg ID code: GRF:SM Reuters ID code: GRLS.

GRF/P:Soc.Bol SIBE Stock Quote - Grifols SA - Bloomberg Markets

Review the latest GRIFOLS SA (GRF:SM) quarterly & annual earnings. Find earnings estimates, revenue estimates and other earnings data for your investing. Stock quote for Grifols, S.A. (GRFS) - Get real-time last sale and extended hours stock prices, company news, charts, and company-specific research tools for.

Grifols Internacional: Accion y capital social

Grifols: 75th anniversary. Our journey of effort, excellence, passion for research, and continuous and strong commitment to the quality and safety of our products. Grifols SA: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information, Mercado Continuo. 11 May 2015 Grifols. 36,17. 44,36. 9,21. 22,6%. Small Caps. Cierre (EUR/acc.) Fuente: Bloomberg y BBVA GMR. Carteras Propuestas 11,689 Grifols Sa.

Grifols, S.A. (Catalan: [??i?f??s]) is a Spanish multinational pharmaceutical and chemical company. Principally a producer of Grifols is the major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products. Bloomberg. El capital social actual de Grifols S.A. asciende a la cifra de 119.603.705 euros, representado por: Acciones Codigo identificacion en Bloomberg: GRF:SM.

14 Ago 2014 Foto: El rey Felipe VI brinda con Victor Grifols en su visita a la planta trimestre por el consenso de analistas recogido por Bloomberg.

Grifols Worldwide: Welcome

Get GRIFOLS SA (GRF:SM) stock research & investing information. Find historical stock quotes, Bloomberg the Company & Products. Bloomberg Anywhere. 25 Jun 2014 Grifols gana el 33% mas hasta marzo. los expertos encuestados por Bloomberg estiman que con cargo a los resultados de este ano su. Ecoprensa S.A. - Todos los derechos reservados, Nota Legal, Politica de cookies. 27 Feb 2014 En las ultimas horas REE, Grifols, Indra y OHL han presentado sus resultados de 2013 de euros (-1%) vs 2.944,9 millones de euros estimado (Bloomberg). Los informes del departamento de Analisis de Bankinter, S.A.